These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 13441532)

  • 1. [Chemistry and pharmacology of a new peroral antidiabetic: ambolin].
    NOHARA FS
    Praxis; 1957 Apr; 46(16):359-61. PubMed ID: 13441532
    [No Abstract]   [Full Text] [Related]  

  • 2. [First results after eight months of ambulant treatment with the peroral diabetic drug ambolin].
    VIOLLIER G
    Praxis; 1957 Apr; 46(16):362-4. PubMed ID: 13441533
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
    [No Abstract]   [Full Text] [Related]  

  • 4. [New peroral treatment of diabetes].
    HUNSKI M
    Lijec Vjesn; 1956; 78(11-12):499-505. PubMed ID: 13450439
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new antidiabetic N-sulfanilyl-N'-butyl urea (BZ 55); preliminary results].
    CHAIA J
    Rev Med Moyen Orient; 1957; 14(1):47-50. PubMed ID: 13454198
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials with a new antidiabetic.
    WEILL J; WEIGEL M
    Strasb Med; 1956 Dec; 7(11):828-38. PubMed ID: 13422046
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new antidiabetic drug, B Z 55].
    BILHAN N; KARKALAS Y
    Turk Tip Cemiy Mecm; 1956 Sep; 22(9):503-17. PubMed ID: 13391990
    [No Abstract]   [Full Text] [Related]  

  • 8. [First experiences with the new oral antidiabetic invenol].
    FIALA E; BALASSA M
    Orv Hetil; 1957 May; 98(21):554-5. PubMed ID: 13452526
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies on peroral therapy of diabetes with a sulfonyl-urea derivative].
    HALLER H
    Z Gesamte Inn Med; 1957 Feb; 12(4):150-8. PubMed ID: 13434239
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications for the peroral management of diabetes with sulfonamides].
    DAMEROW U
    Ther Ggw; 1956 Dec; 95(12):449-51. PubMed ID: 13401398
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peroral diabetes therapy].
    BOLLER R; KOCK E
    Wien Med Wochenschr; 1957 May; 107(18-19):351-5. PubMed ID: 13443325
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peroral therapy of diabetes and preliminary personal experience].
    HUKOVIC S
    Med Arh; 1956; 10(6):15-27. PubMed ID: 13418119
    [No Abstract]   [Full Text] [Related]  

  • 13. [Peroral therapy of diabetes and preliminary personal clinical experience].
    MERLJAK-LUSICKY B
    Med Arh; 1956; 10(6):1-14. PubMed ID: 13418118
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with peroral diabetes therapy, with special consideration of the development of resistance].
    DOTEVALL G
    Sven Lakartidn; 1957 Jun; 54(23):1881-7. PubMed ID: 13455522
    [No Abstract]   [Full Text] [Related]  

  • 15. [Attack-dosed or protracted treatment in peroral therapy of diabetes].
    HOHNLOSER E; FETZNER G; GROPP H; NENNSTIEL HJ
    Medizinische; 1957 Jun; (24):912-3. PubMed ID: 13451009
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ambulatory treatment with an oral antidiabetic].
    ILLIG H; WELLER O
    Munch Med Wochenschr; 1957 Jan; 99(2):40-5. PubMed ID: 13400084
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with an oral antidiabetic drug.
    MENON KP; MOSES SG
    J Indian Med Assoc; 1956 Dec; 27(11):391-6. PubMed ID: 13398631
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral preparations of antidiabetic agents; report of a fatal case.
    FIELD JB; FEDERMAN DD
    Med Ann Dist Columbia; 1957 Jun; 26(6):297-300. PubMed ID: 13440223
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical tests of the antidiabetic sulfa drugs.
    EICHBAUM FW
    Rev Bras Med; 1957 Jan; 14(1):5-11. PubMed ID: 13442028
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood transaminases as indication of tolerance to antidiabetic sulfanylurea].
    PELLEGRINI R
    Boll Soc Ital Biol Sper; 1956 Dec; 32(12):1454-5. PubMed ID: 13446088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.